A veteran biostatistician on the planning document and the dose-selection shortcut that quietly decide whether trials succeed.
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
- What Will Life Science Orgs Do When The AI Bill Comes Through?
- Clinical Trial Standards — What They Are And Why They're Indispensable
- The Data Was Already There: RWE's Real Bottleneck Is People
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
One Day, Clinical Trials Will Represent The Real World
What needs to happen for RWE to reach its full regulatory potential? We discussed this with industry leaders during the One Day Summit, and here are some key takeaways.
-
Exploring The Potential Of Non-Consumer Smartphones In Clinical Trials
We selected and evaluated a non-consumer device, to explore its potential as a reliable tool for home-based ePRO measure administration. Here’s what we learned from this usability testing.
-
Do CROs Need To Reinvent Themselves In 2025?
Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.
-
The Power Of A Collaboration Platform
Using a recent Phase III Endocrinology trial as a primary case study, this article illustrates the qualitative shift from administrative burden to strategic oversight.
-
Minimizing Hurdles For Patients During The eConsent Process
Learn how eConsent digitalizes the trial participant consent process through increasingly simplified models designed to improve comprehension and boost engagement.
-
Streamlined Site Study Start-Up
Explore the critical process of Study Start-Up (SSU) in clinical trials, with an emphasis on the collaborative efforts of sponsors and research sites to enhance efficiency and reduce timelines.
-
Enhancing Activity And Gait Monitoring In Children Using DHTs
Discover how advancements in digital health technology are reshaping pediatric research and enhancing our understanding of physical activity and gait in children.
-
Simple, Cost-Effective Ways To Engage Patients Using eCOA And IRT
Today, patients are exposed to sophisticated technology, which presents a huge opportunity to elevate engagement. Consider some common elements when initiating engagement during clinical development.
-
Unify Your Data With A Centralized eClinical Platform
Despite the challenges associated with large volumes of data, maintaining quality and regulatory compliance, and enhancing patient engagement, the solutions for managing them can be simple and efficient.
-
How To Prepare An IRB Submission For A Remote eConsent Study
IRBs are increasingly supportive of eConsent solution. Even so, researchers may find themselves in need of guidance as they prepare for an eConsent IRB review.
- Two Planning Mistakes That Quietly Sink Clinical Programs
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
RECENT NEWSLETTERS
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality